Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Med.

Sec. Nephrology

Volume 12 - 2025 | doi: 10.3389/fmed.2025.1569730

This article is part of the Research TopicModifiable Risk Factors for Chronic Kidney Disease ProgressionView all 10 articles

A Novelty Biomarker Ins60/ApoA for Predicting Diabetic Kidney Disease in Newly Diagnosed Type 2 Diabetes: A Pilot Study

Provisionally accepted
Binbin  PanBinbin Pan1*Jin  SunJin Sun2Mengqing  MaMengqing Ma1Hao  ZhangHao Zhang1Hao  HuHao Hu2Yuanyuan  LiuYuanyuan Liu2wanwan  Zhangwanwan Zhang2Xin  WanXin Wan1
  • 1Department of Nephrology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China
  • 2Department of Endocrinology, Xuzhou First People’s Hospital, the affiliated Xuzhou Municipal Hospital of Xuzhou Medical University, Xuzhou, China

The final, formatted version of the article will be published soon.

We performed this cross-sectional study to explore probable biomarkers for predicting diabetic kidney disease (DKD) in newly diagnosed type 2 diabetes mellitus (T2DM).A total of 623 patients from Xuzhou first hospital and Nanjing First Hospital were recruited according to the case records system. Patients were grouped via the ratio of albuminuria & creatinine (ACR) (<30mg/g, 30>=mg/g). Biomarkers in different ACR groups were compared by independent sample T-test. Correlation analysis was determined by Pearson or Spearman analysis and binary logistic regression. The receiver operating characteristics (ROC) curve was performed to elucidate the prediction effect of biomarkers on DKD.The levels of total cholesterol, glycated hemoglobin (HbA1c), fast C-peptide, fast insulin and prevalence of hypertension were higher while levels of red blood cell counts (RBC), hemoglobin, ApoA and free triiodothyronine were lower in ACR>=30mg/g group. There was a negative correlation between ACR>=30mg/g and RBC, hemoglobin, albumin, NAFLD (r = -0.094, p =0.02; r = -0.130, p = 0.001; r=-0.137, p =0.001; r = -0.097, p = 0.018) , while positively correlated with high-density lipoprotein, fast blood glucose, hypertension and ratio of 60-minute insulin postprandial and serum apolipoprotein(a) (Ins60/ApoA) were observed (r = 0.134, p =0.001; r = 0.120, p = 0.003; r=0.131, p =0.001; r = 0.359, p = 0.001).. Further, binary logistic regression showed lnIns60/ApoA was an independent influence factor for ACR>=30mg/g. After adjusting for age, gender, hypertension, non-alcoholic fatty liver disease (NAFLD), hemoglobin, albumin, smoking history, alcohol drink history and body mass index (BMI), lnIns60/ApoA was an independent influence factors for ACR>=30mg/g(OR = 2.778, p =0.015). The area under the ROC curve was 0.741 (95% CI:0.629-0.854, p = 0.001) for ACR>=30mg/g. The analysis of ROC curves revealed a best cut-off for ACR was 22.42 mg/g and yielded a sensitivity of 67.6% and a specificity of 72.1%.Ratio of Ins60/ApoA could be used as an alternative biomarker for predicting DKD in newly diagnosed T2DM patients.

Keywords: Ins60/ApoA, ratio of albuminuria & creatinine, Newly diagnosed type 2 diabetes, Diabetic kidney disease, Body Mass Index

Received: 01 Feb 2025; Accepted: 25 Aug 2025.

Copyright: © 2025 Pan, Sun, Ma, Zhang, Hu, Liu, Zhang and Wan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Binbin Pan, Department of Nephrology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.